CASCADES INC. Institutional Investor Roadshow Western Canada May - - PowerPoint PPT Presentation

cascades inc
SMART_READER_LITE
LIVE PREVIEW

CASCADES INC. Institutional Investor Roadshow Western Canada May - - PowerPoint PPT Presentation

CASCADES INC. Institutional Investor Roadshow Western Canada May 26-27, 2014 DISCLAIMER Certain statements in this presentation, including statements regarding future results and performance, are forward-looking statements within the


slide-1
SLIDE 1

CASCADES INC.

Institutional Investor Roadshow – Western Canada May 26-27, 2014

slide-2
SLIDE 2

Certain statements in this presentation, including statements regarding future results and performance, are forward-looking statements within the meaning of securities legislation based on current expectations. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause actual results to differ materially from those projected, including, but not limited to, the effect of general economic conditions, decreases in demand for the Corporation’s products, the prices and availability of raw materials, changes in the relative values of certain currencies, fluctuations in selling prices and adverse changes in general market and industry conditions. This presentation may also include price indices as well as variance and sensitivity analyses that are intended to provide the reader with a better understanding of the trends related to

  • ur business activities. These items are based on the best estimates available to the Corporation.

The financial information included in this presentation also contains certain data that are not measures of performance under IFRS (“non-IFRS measures”). For example, the Corporation uses earnings before interest, taxes, depreciation and amortization (EBITDA) because it is the measure used by management to assess the

  • perating and financial performance of the Corporation’s operating segments. Such information is reconciled to

the most directly comparable financial measures, as set forth in the “Supplemental Information on Non-IFRS Measures” section of our most recent quarterly report or annual report. Specific items are defined as items such as charges for or reversal of impairment of assets, for facility or machine closures, accelerated depreciation of assets due to restructuring measures, debt restructuring charges, gains or losses on sales of business units, unrealized gains or losses on derivative financial instruments that do not qualify for hedge accounting, foreign exchange gains or losses on long-term debt and other significant items of an unusual or non-recurring nature. All amounts in this presentation are in Canadian dollars unless otherwise indicated.

DISCLAIMER

2 ¡

slide-3
SLIDE 3

3 ¡

INTRODUCTION

Our recent performance and financial situation

  • Cost inflation in 2011/2012 but less volatile cost environment at the moment
  • Low economic growth in Canada and Europe but favorable FX
  • Productivity and profitability improving è more to come
  • 2011 negatively impacted our leverage ratios but the situation is improving

Where we come from

  • Unique culture – green visionaries, turnarounds, entrepreneurial philosophy
  • Business model challenged by strong CAD$ and higher recycled fibre costs

Our action plan

  • Started at the end of 2011: a lot has been done but not completed yet
  • Investments reflected on balance sheet but not yet in results
  • New state-of-the-art Greenpac mill ramping-up according to plan

ü ü ü ü ü ü

Doing all the right things to improve a success story

slide-4
SLIDE 4

OVERVIEW OF OUR OPERATIONS

Green packaging and tissue product offering

4 ¡

Packaging Products Tissue Papers Containerboard Boxboard Europe Specialty Products

1st tissue paper

producer in Canada

4th in North America 1st

paper collector in Canada

2nd

producer in Europe

1st containerboard

producer in Canada

6th in North America

Leading NA packaging and tissue manufacturer with substantial recycling capabilities

slide-5
SLIDE 5

100+ business units

34 units2 20 units 58 units2 Trims and rejects sent to recycling centers

77% recycled fibre (3.0M tons) NA integration rate (2013): 27% (0.55M tons)

NA integration rate (2013):

  • Containerboard Group1 56%
  • Tissue Papers Group 70%

Upstream and downstream integration in North America

CLIENTS

1 Integration rate for our containerboard activities in North America. 2 Including Reno De Medici’s units and Greenpac. Also including 7 manufacturing/converting tissue papers units which are counted in both Converting and Manufacturing.

OVERVIEW OF OUR OPERATIONS

Closed-loop business model

slide-6
SLIDE 6

OVERVIEW OF OUR OPERATIONS

Balanced play in less cyclical sectors

6 ¡

Packaging Products

74% of Sales 69% of EBITDA

Cascades

Q1-2014 LTM Sales: $3,929M Q1-2014 LTM EBITDA: $364M Q1-2014 LTM EBITDA Margin: 9% Tissue Papers

26% of Sales 31% of EBITDA Containerboard

33% of Sales 38% of EBITDA

Boxboard Europe

22% of Sales 16% of EBITDA

Specialty Products

19% of Sales 15% of EBITDA

EBITDA excluding specific items. Breakdown of sales and EBITDA before eliminations & corporate activities.

EBITDA Margin: 11% EBITDA Margin: 7% EBITDA Margin: 7% EBITDA Margin: 12%

Exposure to two healthiest sectors in Pulp and Paper industry

slide-7
SLIDE 7

3,182 3,625 3,645 3,849 3,929 2,500 3,000 3,500 4,000 4,500 2010 2011 2012 2013 LTM 03/31/2014 (M CAN$)

SALES

310 229 304 352 364 100 200 300 400 2010 2011 2012 2013 LTM 03/31/2014 (M CAN$)

EBITDA

OUR FINANCIAL PERFORMANCE

Historical performance

EBITDA excluding specific items. Note 1 – Elimination of joint venture consolidation Note 2 – Impact of Dopaco divestiture and elimination of joint venture consolidation

7 ¡ IFRS

1 2

IFRS

Results progressing as productivity, FX and pricing environment improve

slide-8
SLIDE 8

OUR FINANCIAL PERFORMANCE

Historical segmented EBITDA

EBITDA excluding specific items.

8 ¡

21 23 26 25 25 33 42 46 33

0% 4% 8% 12% 16% 12 24 36 48 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014 (% of sales) (M CAN$)

Containerboard

13 11 7 11 11 10 9 21 23

0% 4% 8% 12% 16% 7 14 21 28 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014 (% of sales) (M CAN$)

Boxboard Europe

11 15 15 8 11 16 15 16 12

0% 3% 6% 9% 12% 5 10 15 20 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014 (% of sales) (M CAN$)

Specialty Products

33 39 35 31 29 33 39 32 20

0% 5% 10% 15% 20% 11 22 33 44 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014 (% of sales) (M CAN$)

Tissue Papers

slide-9
SLIDE 9

100 200 300 400 500 600 700 800 600 700 800 900 1 000 1 100 1 200 1 300 1 400 1 500 1 600

Jan 11 Mar 11 May 11 July 11 Sept 11 Nov 11 Jan 12 Mar 12 May 12 July 12 Sept 12 Nov 12 Jan 13 Mar 13 May 13 July 13 Sept 13 Nov 13 Jan 14 Mar 14

Tissue Papers - Selected Products

Virgin parent rolls Recycled parent rolls Cascades' raw materials index (US$/s.t.) (US$/s.t.)

500 550 600 650 700 750 800

Jan 11 Mar 11 May 11 July 11 Sept 11 Nov 11 Jan 12 Mar 12 May 12 July 12 Sept 12 Nov 12 Jan 13 Mar 13 May 13 July 13 Sept 13 Nov 13 Jan 14 Mar 14 May 14

Containerboard - Selected Products

Linerboard 42-lb Corrugating medium 26-lb (US$/s.t.)

OUR BUSINESS DRIVERS – PRICES

9 ¡

  • Prices relatively stable throughout the year

2013 and 2014

  • Recycled grade prices under pressure:
  • Additional capacity coming to market
  • Reasonable recovered paper prices

Beneficial containerboard price increases; temporary pressures in tissue

slide-10
SLIDE 10

50 100 150 200 250 300 2,000 2,500 3,000 3,500 4,000 4,500

Jan ¡2009 Apr ¡2009 Jul ¡2009 Oct ¡2009 Jan ¡2010 Apr ¡2010 Jul ¡2010 Oct ¡2010 Jan ¡2011 Apr ¡2011 Jul ¡2011 Oct ¡2011 Jan ¡2012 Apr ¡2012 Jul ¡2012 Oct ¡2012 Jan ¡2013 Apr ¡2013 Jul ¡2013 Oct ¡2013 Jan ¡2014 Apr ¡2014

Kraft-­‑Top ¡liner ¡175g ¡-­‑ ¡Domestic ¡Price ¡-­‑ ¡China ¡(RMB/tonne) OCC ¡(11) ¡-­‑ ¡US ¡-­‑ ¡LA/SF ¡export ¡to ¡China ¡-­‑ ¡CFR ¡(US$/ton)

50 100 150 200 250 300

Jan 11 Apr 11 July 11 Oct 11 Jan 12 Apr 12 July 12 Oct 12 Jan 13 Apr 13 July 13 Oct 13 Jan 14 Apr 14

(US$/ton)

White grades (SOP) Brown grades (OCC) Sources: RISI

10 ¡

110 160

OUR BUSINESS DRIVERS – RAW MATERIAL COSTS

US OCC Costs Highly Correlated with Asian Board Market Recycled Fiber North American List Prices

  • Experts estimate Chinese collection rate at approx. 46%
  • Will increase as domestic consumption increases

Current (May)

Partially due to harsh weather, brown grades increased by $15/s.t. In March

slide-11
SLIDE 11

OUR BUSINESS DRIVERS – RAW MATERIAL STRATEGY

Our North American Recycled Fibre Supply

  • Short term:
  • constant review of our inventory

strategy

  • Long term:
  • ensure control over fiber supply
  • develop substitute grades
  • potential to increase virgin

content in certain circumstances

  • continue to close the loop with

customers retailers Our Strategy

11 ¡

2013 Currently control

  • ver 60% of our

fibre supply despite greater concentration

  • n the supply

side

Spot Purchase 37% Contractual Agreement 35%

Cascades Recovery and Internal 28%

Largest recycled paper collector in Canada

slide-12
SLIDE 12

50 60 70 80 90 100 110 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00

Q1-11 Q2-11 Q3-11 Q4-11 Q1-12 Q2-12 Q3-12 Q4-12 Q1-13 Q2-13 Q3-13 Q4-13 Q1-14

Crude oil (US$) Natural gas (US$)

Natural gas (US$/mmBtu) Crude oil (US$/barrel)

0.60 0.65 0.70 0.75 0.80 0.85 0.90 0.95 0.75 0.80 0.85 0.90 0.95 1.00 1.05 1.10

Q1-11 Q2-11 Q3-11 Q4-11 Q1-12 Q2-12 Q3-12 Q4-12 Q1-13 Q2-13 Q3-13 Q4-13 Q1-14

Euro€/CAN$ US$/CAN$

US$/CAN$ Euro€/CAN$

OUR BUSINESS DRIVERS – ENERGY AND FX

12 ¡

  • EBITDA sensitivity of $5M to every change of

0.01 CAN$ vs US$ A prolonged weakness of the CAN$ would be a game changer Energy costs higher than last year Recent price increase for natural gas; recent reversal of the CAN$

Sources: Bloomberg

slide-13
SLIDE 13

Improve our ROCE to reach our cost of capital Reach industry comparable leverage ratios ACTION PLAN PRIORITIES MEDIUM TERM OBJECTIVES Modernize core operations through focused investments Optimize capital allocation and reduce working capital Restructure underperforming units

2 3 1

Innovate to improve and develop processes and products

4

OUR STRATEGIC ACTION PLAN

Four priorities

13 ¡

Improving our profitability and financial situation through our Action Plan

slide-14
SLIDE 14

Modernize core operations through focused investments

1

14 ¡

Initiatives undertaken since the beginning of our Action Plan

Containerboard – Manufacturing Containerboard – Converting

  • Construction of the Greenpac linerboard mill in Niagara Falls, NY
  • Consolidation of our platform in Ontario
  • Consolidation of our folding carton platform in Canada
  • Installation of a new paper machine in Oregon (Q4-2014)
  • Additional converting capacity in Arizona early in 2014

Boxboard – Converting Tissue Papers – Manufacturing Tissue Papers – Converting

slide-15
SLIDE 15

15 ¡

  • Satisfied with productivity and board quality
  • Average production Q1-2014: 944 tons/day
  • Produced to capacity for a few days in April
  • Positive EBITDA since Q4-2013
  • Largest recycled linerboard mill in NA:
  • 1,500 s.t./day of lightweight

recycled linerboard (26 pounds)

  • Product differentiation
  • State-of-the-art equipment
  • Take-or-pay agreement for 81% of the

mill’s output

  • Significant ownership at 59.7%
  • Partners include a pension fund

and two independent converters Key Facts

OUR NEW GREENPAC LINERBOARD MILL

Modernize core operations through focused investments

1

Ramp-up Highlights

slide-16
SLIDE 16

ILLUSTRATIVE GREENPAC CONTRIBUTION TO EPS

16 ¡ ±

Sensitivity

±

Greenpac has the potential to contribute significantly to Cascades EPS

Cascades' EPS (excluding specific items) 2011 ($0.14) 2012 $0.05 2013 $0.31 LTM 03/31/2014 $0.36 Greenpac Depreciation Income Net CAS' CAS' share of Impact on Value per share EBITDA & Interest tax (39%) income interest income Cascades using 7x (M$) (M$) (M$) (M$) (M$) EPS EBITDA multiple 60 40 8 12 59.7% 7 $0.08 $0.76 80 40 16 24 59.7% 15 $0.16 $1.65 100 40 23 37 59.7% 22 $0.23 $2.54 10 $0.45

slide-17
SLIDE 17

Œ

Smurfit Stone 20%

v

Weyerhaeuser 16%

w

IP 11%

x

Georgia Pacific 11%

y

Temple Inland 9%

‘

PCA 6%

’

Cascades 3% Others 24% Top-5 67%

THE CONTAINERBOARD MARKET

17 ¡

Changing landscape: Leading 3 North American Producers representing 62% of the market

% of total capacity

2007 Industry Participants

Œ

IP 33%

v

Rock Tenn 19%

w

Koch/GP 10%

x

PCA 10%

y

Kapstone 4%

‘

Cascades 4%

’

Pratt 3% Others 17% Top-5 76% 2013 Industry Participants Cascades has maintained its market share in a consolidated industry

Sources: Company reports and estimates, RISI, Fiber Box Association, Paper Packaging Canada Cascades’ capacity includes 100% of Greenpac

slide-18
SLIDE 18

14.8% 15.0% 14.8% 14.4% 14.0%13.5% 13.1% 12.9%12.9%

8.0% 10.0% 12.0% 14.0% 16.0% Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014

LTM Working Capital (% of LTM Sales)

Optimize capital allocation and reduce working capital

2

18 ¡

Selected initiatives undertaken since the beginning of our Action Plan Corporate – Working cap initiative

  • Acquisition and conversion of Boise

paper machine next to our existing tissue machine to:

  • increase our capacity by 55,000 tons
  • n a faster timeline
  • improve the overall operating

efficiency of the mill

  • increase market reach at a reduced

capital cost per ton

  • $35M cost and start-up in Q4-2014

Tissue Papers – Western US

slide-19
SLIDE 19

THE TISSUE PAPERS MARKET

19 ¡

Sources: RISI, Company reports and estimates

Future capacity additions CAGR of 1.9%, not so far from annual consumption growth Top 5 – North American Tissue Producers

Œ

Koch/GP 29%

v

P&G 16%

w

Kimberly-Clark 15%

x

Cascades 7%

y

SCA 6% Others 27% Total - 2013 8,671

% of total capacity 211 470 157 149 8,000 8,400 8,200 9,400 9,200 9,000 8,800 8,600

2017

9,352

New capacity 2015

9,141

New capacity 2013

8,671

New capacity 2011

8,514

New capacity 2009

8,365

New capacity has more impact on brands but trickles-down to other products

slide-20
SLIDE 20

Retail 45%

Parent rolls 15%

AfH 40% 20 ¡

Cascades’ Tissue Papers 2013 Sales – End-Users

Branded 56% Private label 44%

Cascades’ Tissue Papers 2013 Sales – Countries

Branded 14%

Private label 86%

Retail 53% AfH 47% Retail 52% AfH 48%

Canada (30%) US (70%)

96% private label 38% branded

OUR POSITIONNING IN THE TISSUE PAPERS SEGMENT

Optimize capital allocation and reduce working capital

2

slide-21
SLIDE 21

21 ¡

  • Valuation does

not fully reflect growth potential

  • Current BLX

share price: ~ $14.00 - represents ± $2.00/share for CAS

OUR EQUITY INVESTMENT IN BORALEX

Boralex has tremendous pipeline of projects

1 Refer to Boralex’s presentations 2 Refer to Boralex’s presentations

slide-22
SLIDE 22

Restructure underperforming units – now 2nd producer of boxboard in Europe

Villa ¡S. ¡Lucia 220k ¡tons ¡recycled ¡ WLC Blendecques 110k ¡tons ¡recycled ¡ WLC Almazan 35k ¡tons ¡recycled ¡ WLC Magenta Idle Arnsberg 220k ¡tons recycled ¡WLC Ovaro 95k ¡tons ¡recycled ¡ WLC ¡ ¡& other ¡ grades

  • S. ¡Giustina

220k ¡tons ¡recycled ¡ WLC Llica de ¡val (Barcelona) Sheeting ¡centre Cascades mills Djupafors Closure: ¡6-­‑15-­‑2014 La ¡Rochette 150k ¡tons ¡virgin ¡ FBB Careo – sales offices RdM mills and plants

  • Results from 2007 transaction: we received a 31% interest in exchange for our recycled

mills

  • We now own ~58% of public Italian company (fully consolidated in our EBITDA)
  • Allowed for rationalization of production capacity and amalgamation of sales forces

RdM achievements

  • From 10 to 7 machines with

same production capacity

  • Implementation of

Paneuropean direct sales network

  • > €90M of capex to

modernize asset base

  • €12M of fixed cost saving

program achieved

OUR INTEREST IN RENO AND OUR EUROPEAN PLATFORM

22 ¡

3

slide-23
SLIDE 23

Restructure underperforming units

3

23 ¡

Difficult decisions taken since the beginning of our Action Plan

  • 14 closures
  • Containerboard: 1 manufacturing mill + 5 converting plants
  • Boxboard North America: 1 converting plant
  • Boxboard Europe: 2 mills + 1 paper machine; closure of our Sweden boxboard mill to
  • ccur on June 15, 2014
  • Specialty Products: 1 pulp mill + 1 specialty packaging plant
  • Tissue: 1 napkin plant
  • 4 sales
  • Containerboard – Manufacturing

Avot-Vallée mill

  • Boxboard – Manufacturing

Versailles mill

  • Boxboard – Converting

Dopaco business, Hebron plant

slide-24
SLIDE 24

Innovate to improve and develop processes and products

4

24 ¡

Moka – Beige bath tissue Antibacterial Towel Ultrafit – Cup tray Won prestigious HAVI Global Supplier of the Year and McDonald’s System First Award Won prestigious Innovative Technology by Novation EVOKTM – Polystyrene foam packaging using recycled material

Some of our activities aim at achieving 10% of sales from new products

slide-25
SLIDE 25

OUR SPECIALTY PRODUCTS GROUP

2013 sales of $965M in four main sectors of activities (including joint ventures)

25 ¡

Recycling and Recovery (20 units)

  • 32% of sales
  • Largest recycled

paper collector in Canada

Specialty Papers (6 units) Industrial Packaging (12 units) Consumer Packaging (7 units)

  • 37% of sales
  • Eco-friendly fine and

security papers

  • 16% of sales
  • Leading producer of

papermill packaging

  • $10-15M EBITDA

under equity method

  • 15% of sales
  • Largest

producer of honeycomb in Canada

Stable source of revenues and platform for innovation

slide-26
SLIDE 26

OUR FINANCIAL SITUATION

Investment program

26 ¡

Capital Expenditures Distribution for FY2013 - $157M

  • Capital expenditures for 2013 stood at $172M

($157M excluding IT)

  • 2014 level to revolve around $160M, including IT
  • Including ~$60-70M of maintenance capex
  • Amount subject to change depending on
  • perating results and economic conditions
  • Mostly dedicated towards tissue activities

Corporate 10% Boxboard Europe 18% Tissue papers 30% Container- board 28% Specialty Products 14%

By segment

Gradual capex program to improve asset base

slide-27
SLIDE 27

3.3x 4.5x 5.8x 5.0x 4.6x 4.7x 3.0x 4.0x 5.0x 6.0x 7.0x 2009 2010 2011 2012 2013 LTM 03/31/2014

Net debt / LTM EBITDA

4.6x 2.9x 2.5x 3.0x 3.4x 3.4x 1.0x 2.0x 3.0x 4.0x 5.0x 2009 2010 2011 2012 2013 LTM 03/31/2014

Interest Coverage Ratio

27 ¡

Net debt to EBITDA ratio should continue to improve in 2014

Cascades’ bank debt financial covenant ratios: Net funded debt to capitalization < 65% (currently at 56%),interest coverage ratio > 2.25x (currently at 3.2x).

OUR FINANCIAL SITUATION

Financial Ratios & Debt Maturities

2016 47% 2017 35% 2020 18%

Long-term Debt Maturities Distribution

slide-28
SLIDE 28

170 125 88 57 19 1,200 1,400 1,650 1,350 1,550 1,500 1,600 1,300 1,450 1,250 1,700 1,750

  • Var. in non-

cash work. cap. components Cash flow from op. (286) ¡ Net Debt 12/31/2012 1,535 ¡ Dividends paid Net Debt 03/31/2014 1,708 ¡ Capital investments, net F/X Rate Investments and others

+11%

F/X rate and working capital are the main reasons of the net debt increase

Q1 2014 net debt includes $120 million of non-recourse net debt of Reno De Medici and other unrestricted subsidiaries.

28 ¡

(M CAN$)

OUR FINANCIAL SITUATION

Net Debt Reconciliation

slide-29
SLIDE 29

29 ¡

Comparable Companies Illustrative Cascades’ Selected Illustrative Trading Range LTM EBITDA Multiple Value

TEV/L

TM EBITDA

(M$ rounded, net corp. activities) (conservative) (M$ rounded) •

  • T

issue Papers 8.5x – 11.5x 124 7.5x 930

  • Containerboard

6.5x - 10.0x 154 6.5x 1,001

  • Boxboard Europe

6.0x - 9.0x 63 6.0x 378

  • Specialty Products

7.0x - 11.0x 59 6.0x 354

  • Corporate activities

(36) 6.0x (216) 364 6.7x Total Enterprise Value 2,447 Add: JV contribution ($10M EBITDA @ 6.0x) 60 Subtract: Net Debt (1,708) Total Equity Value – pre-adjustments 799 Add: Boralex’ stake (at market value) 183 Add: Greenpac investment (at cost) 140 Subtract: Minority interest (estimate at market value) (124) Total Equity Value – post-adjustments 998 Per share 10.63$ Current Market Capitalization 558 Current Market Price (as at May 20, 2014) $5.94

ILLUSTRATIVE SUM-OF-THE-PARTS VALUATION ANALYSIS

Share trading at discount, even using conservative multiples

Refer to Notes included in this presentation For illustration purposes only. Value by segment do not necessary reflect the Corporation’s view on their respective value

1 2

slide-30
SLIDE 30

POTENTIAL BENEFITS STEMMING FROM OUR RECENT INITIATIVES

30 ¡

Other sources of growth and incremental value

  • Culture of innovation
  • European platform and Boralex

Modernizing our operating platform to increase profitability

  • ±$150M capex program per year, including ERP upgrade
  • Divestitures and closures of under-performing units
  • Containerboard: great fundamentals and improved platform
  • Modernized converting platform and manufacturing productivity improvement
  • Greenpac has the potential to contribute to EPS in 2014
  • Tissue Papers: strong and growing position
  • Increasing presence in the US and recent expansion announcement in the West
  • Better performance from ATMOS tissue paper machine

Potential tailwinds

  • CAD$ weakness
  • Chinese’s economy weakness and impact on recovered paper prices

ü ü ü ü ü ü

Taking the right steps to position Cascades for the future

slide-31
SLIDE 31

NOTES

1. Comparable companies include:

  • Graphic Packaging, IP, Kapstone, Meadwestvaco, Packaging Corp. and Rock Tenn for Containerboard.
  • KP Tissue, Clearwater Paper, Kimberly-Clark and Orchids Paper for Tissue Papers. Wausau Papers trailing multiple not considered.
  • Holmen, Mayr Melhnof , Mesta Board and Stora Enso for Boxboard Europe.
  • Sonoco, CCL, Domtar, Greif, Sealed Air and Winpak for Specialty Products.

2. Minority interest adjustments estimated for Reno (assuming 58% ownership) and Cascades Recovery (73% ownership). The capacity utilization rate is defined as: Shipments/Practical capacity. Paper manufacturing only. Working capital includes accounts receivable (excluding the short term portion of other assets) plus inventories less accounts payable.

31 ¡

For more information: www.cascades.com/investors Riko Gaudreault, CFA, ASA Director, Investor Relations riko_gaudreault@cascades.com 514-282-2697